NomosLogic Inc
Categories
Drug Discovery & Development Neurology Oncology Cell & Gene Therapy Commercialization Cardiovascular
About
NomosLogic is a Salt Lake City-based clinical genomics infrastructure company building the deterministic interpretation layer beneath modern medicine. The platform fuses genomic data with the full output of the clinical lab, including chemistry, hematology, urinalysis, and therapeutic drug monitoring, and returns audit-ready clinical decisions in seconds, not weeks. The clinical engine is rule-based, fully traceable, and SHA-256 anchored to the rule version that produced every assertion. Pharmacogenomics is the wedge: 362+ FDA drug labels covered, with closed-loop decision support that pairs predicted phenotype with measured patient context. The architecture spans 496,805 variant nomenclature mappings, 1.25 million active Clinical Logic Objects, and sub-130-second whole-genome execution.
Additional Info
NomosLogic is a Salt Lake City-based clinical genomics infrastructure company. The platform delivers deterministic, audit-ready interpretation across genomic, chemistry, hematology, and pharmacogenomic data, returning structured clinical decisions in seconds. NomosLogic is building the infrastructure layer that the next decade of precision medicine will run on.
NomosLogic is positioning Utah at the center of the next decade of clinical genomics: deterministic, auditable, and built to survive regulation.
Membership Type
Emerging Industry Member
Contacts
Matthew Hardy
Founder/CEO